BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34363821)

  • 1. Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.
    Hunter EJ; Hamaia SW; Gullberg D; Malcor JD; Farndale RW
    Toxicol Appl Pharmacol; 2021 Oct; 428():115669. PubMed ID: 34363821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vimocin and vidapin, cyclic KTS peptides, are dual antagonists of α1β1/α2β1 integrins with antiangiogenic activity.
    Momic T; Katzehendler J; Benny O; Lahiani A; Cohen G; Noy E; Senderowitz H; Eble JA; Marcinkiewicz C; Lazarovici P
    J Pharmacol Exp Ther; 2014 Sep; 350(3):506-19. PubMed ID: 24939421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
    Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
    Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
    Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
    Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptors promote α1β1- and α2β1-integrin mediated cell adhesion to collagen by enhancing integrin activation.
    Xu H; Bihan D; Chang F; Huang PH; Farndale RW; Leitinger B
    PLoS One; 2012; 7(12):e52209. PubMed ID: 23284937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of α2β1 integrin inhibitor VP-i with anti-platelet properties in the venom of Vipera palaestinae.
    Arlinghaus FT; Momic T; Ammar NA; Shai E; Spectre G; Varon D; Marcinkiewicz C; Heide H; Lazarovici P; Eble JA
    Toxicon; 2013 Mar; 64():96-105. PubMed ID: 23319078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of VP12 and viperistatin on inhibition of collagen-receptor-dependent melanoma metastasis.
    Staniszewska I; Walsh EM; Rothman VL; Gaathon A; Tuszynski GP; Calvete JJ; Lazarovici P; Marcinkiewicz C
    Cancer Biol Ther; 2009 Aug; 8(15):1507-16. PubMed ID: 19502781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma.
    Bazan-Socha S; Bukiej A; Pulka G; Marcinkiewicz C; Musial J
    Clin Exp Allergy; 2006 Sep; 36(9):1184-91. PubMed ID: 16961719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins alpha2beta1 and alpha11beta1.
    Caswell CC; Barczyk M; Keene DR; Lukomska E; Gullberg DE; Lukomski S
    J Biol Chem; 2008 Dec; 283(52):36168-75. PubMed ID: 18990704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinocetin, a venom-derived integrin-specific antagonist inhibits collagen-induced platelet and endothelial cell functions.
    Vaiyapuri S; Hutchinson EG; Ali MS; Dannoura A; Stanley RG; Harrison RA; Bicknell AB; Gibbins JM
    J Biol Chem; 2012 Jul; 287(31):26235-44. PubMed ID: 22689571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer.
    Grzesiak JJ; Bouvet M
    Pancreas; 2007 Mar; 34(2):220-8. PubMed ID: 17312461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crucial role of collagen-binding integrins in maintaining the mechanical properties of human scleral fibroblasts-seeded collagen matrix.
    Hu S; Cui D; Yang X; Hu J; Wan W; Zeng J
    Mol Vis; 2011; 17():1334-42. PubMed ID: 21647271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.
    Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
    Invest New Drugs; 2019 Oct; 37(5):1044-1051. PubMed ID: 30680583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth.
    Brown MC; Staniszewska I; Del Valle L; Tuszynski GP; Marcinkiewicz C
    Int J Cancer; 2008 Nov; 123(9):2195-203. PubMed ID: 18712720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin α1β1 using collagen toolkits II and III.
    Hamaia SW; Pugh N; Raynal N; Némoz B; Stone R; Gullberg D; Bihan D; Farndale RW
    J Biol Chem; 2012 Jul; 287(31):26019-28. PubMed ID: 22654115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1.
    Lahav J; Wijnen EM; Hess O; Hamaia SW; Griffiths D; Makris M; Knight CG; Essex DW; Farndale RW
    Blood; 2003 Sep; 102(6):2085-92. PubMed ID: 12791669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
    Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
    Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrins α2β1 and α11β1 regulate the survival of mesenchymal stem cells on collagen I.
    Popov C; Radic T; Haasters F; Prall WC; Aszodi A; Gullberg D; Schieker M; Docheva D
    Cell Death Dis; 2011 Jul; 2(7):e186. PubMed ID: 21796158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The integrin-collagen connection--a glue for tissue repair?
    Zeltz C; Gullberg D
    J Cell Sci; 2016 Feb; 129(4):653-64. PubMed ID: 26857815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.
    Jakubowski P; Calvete JJ; Eble JA; Lazarovici P; Marcinkiewicz C
    Toxicol Appl Pharmacol; 2013 May; 269(1):34-42. PubMed ID: 23499869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.